Literature DB >> 22814923

[Subretinal hemorrhage. Natural course and staging].

S Bopp1.   

Abstract

Subretinal hemorrhages are a complication of various diseases which arise from the choroidal or retinal circulation. Most commonly the underlying pathology is a choroidal neovascular membrane (CNV) especially in patients with age-related macular degeneration (AMD). Less common ocular diseases are those with non-AMD-related CNV and retinal arterial macroaneurysms (RAM). Case studies have demonstrated a poor prognosis, however, a significant portion have favorable outcomes. Therefore, therapeutic decision-making is difficult. As a major difficulty in comparing different treatment modalities for submacular hemorrhages is the lack of a standardized definition of the extent of the hemorrhage. A classification for AMD-related subretinal hemorrhages including size, thickness and intraretinal location is suggested.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22814923     DOI: 10.1007/s00347-012-2563-6

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  21 in total

1.  Clinicopathological correlation of retinal pigment epithelial tears in exudative age related macular degeneration: pretear, tear, and scarred tear.

Authors:  B A Lafaut; S Aisenbrey; C Vanden Broecke; R Krott; C P Jonescu-Cuypers; S Reynders; K U Bartz-Schmidt
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

2.  Variations in the clinical course of submacular hemorrhage.

Authors:  M H Berrocal; M L Lewis; H W Flynn
Journal:  Am J Ophthalmol       Date:  1996-10       Impact factor: 5.258

3.  Fibrin directs early retinal damage after experimental subretinal hemorrhage.

Authors:  C A Toth; L S Morse; L M Hjelmeland; M B Landers
Journal:  Arch Ophthalmol       Date:  1991-05

4.  Prospective one-year study of ranibizumab for predominantly hemorrhagic choroidal neovascular lesions in age-related macular degeneration.

Authors:  Margaret A Chang; Diana V Do; Susan B Bressler; Sandra D Cassard; Emily W Gower; Neil M Bressler
Journal:  Retina       Date:  2010-09       Impact factor: 4.256

5.  Nonsurgical management of macular hemorrhage secondary to retinal artery macroaneurysms.

Authors:  C M McCabe; H W Flynn; W C McLean; R D Brod; H R McDonald; M W Johnson; G A Williams; W F Mieler
Journal:  Arch Ophthalmol       Date:  2000-06

6.  Natural history of macular subretinal hemorrhage in age-related macular degeneration.

Authors:  A Scupola; G Coscas; G Soubrane; E Balestrazzi
Journal:  Ophthalmologica       Date:  1999       Impact factor: 3.250

7.  Visual prognosis for symptomatic retinal arterial macroaneurysm.

Authors:  Toshie Tonotsuka; Masahito Imai; Katsuya Saito; Hiroyuki Iijima
Journal:  Jpn J Ophthalmol       Date:  2003 Sep-Oct       Impact factor: 2.447

Review 8.  Management of submacular hemorrhage.

Authors:  Matthew T S Tennant; Jesus L Borrillo; Carl D Regillo
Journal:  Ophthalmol Clin North Am       Date:  2002-12

9.  Multinucleated giant cells on Bruch's membrane late in recurrent retinal and subretinal hemorrhaging.

Authors:  J R Wolter; G O Till
Journal:  Ophthalmologica       Date:  1989       Impact factor: 3.250

10.  Experimental subretinal hemorrhage in rabbits.

Authors:  H Glatt; R Machemer
Journal:  Am J Ophthalmol       Date:  1982-12       Impact factor: 5.258

View more
  6 in total

1.  [Forms of age-related macular degeneration].

Authors:  M Schargus
Journal:  Ophthalmologe       Date:  2015-04       Impact factor: 1.059

Review 2.  [Prognosis and treatment of macular bleeding in neovascular age-related macular degeneration].

Authors:  H T Agostini; S Bopp; N Feltgen
Journal:  Ophthalmologe       Date:  2017-05       Impact factor: 1.059

3.  [Massive subretinal hemorrhage and anticoagulants. An unfortunate combination?].

Authors:  C Kuhli-Hattenbach; W Miesbach; I Scharrer; L-O Hattenbach
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

4.  [Spontaneous intraocular hemorrhage under oral anticoagulation : Apixaban in comparison to phenprocoumon].

Authors:  M Treder; M Alnawaiseh; G Wirths; A Rosentreter; N Eter
Journal:  Ophthalmologe       Date:  2018-07       Impact factor: 1.059

5.  Incidence of submacular haemorrhage (SMH) in Scotland: a Scottish Ophthalmic Surveillance Unit (SOSU) study.

Authors:  Aws Al-Hity; David H Steel; David Yorston; David Gilmour; Zachariah Koshy; David Young; Jost Hillenkamp; Gerard McGowan
Journal:  Eye (Lond)       Date:  2018-10-29       Impact factor: 3.775

Review 6.  [Management of submacular hemorrhage : What, when, how?]

Authors:  Lars-Olof Hattenbach; Salvatore Grisanti; Nicolas Feltgen; Argyrios Chronopoulos
Journal:  Ophthalmologe       Date:  2020-09       Impact factor: 1.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.